Cited by 187Advanced MRI Techniques and ApplicationsCharacterization and Applications of Magnetic NanoparticlesLanthanide and Transition Metal Complexes

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide

Hamm, Bernd, Staks, Thomas, Taupitz, Matthias, Maibauer, Renate, Speidel, Andrea, Huppertz, Alexander, Frenzel, Thomas, Lawaczeck, Rüdiger, Wolf, Karl J., Lange, Lothar·1994·Journal of Magnetic Resonance Imaging

DOI 10.1002/jmri.1880040508

Open this paper in CoChat — free account

Abstract

The aim of this prospective study was to obtain the first human safety and magnetic resonance (MR) imaging results with a new formulation of superparamagnetic iron oxide (SPIO) (SHU 555 A). The SPIO was tested at four iron doses, from 5 to 40 mumol/kg. Laboratory tests and clinical measurements were done in 32 healthy volunteers for up to 3 weeks after administration. MR imaging at 1.5 T was performed before and 8 hours to 14 days after fast intravenous injection (500 mumol Fe/min) of the SPIO (six subjects per dose). Results of this phase I study demonstrate that SHU 555 A at a concentration of 0.5 mol Fe/L was well tolerated. A dose-dependent minor increase in activated partial thromboplastin time, which remained within the normal range, was seen. All doses of SPIO caused a signal loss in both liver and spleen (P < .05) with a spin-echo sequence (TR = 2,300 msec, TE = 45 msec). The signal losses in the liver 8 hours after contrast agent injection were 58%, 79%, 82%, and 87% for the 5, 10, 20, and 40 mumol Fe/kg doses, respectively. The corresponding signal losses in the spleen were 23%, 45%, 65%, and 78%, respectively. The doses that reduced signal intensity by half were 3.1 mumol Fe/kg for the liver and 12.8 mumol Fe/kg for the spleen. The results suggest that the new SPIO formulation is a safe and efficient MR contrast agent.

Integrity signals

Registry

Crossref · 10.1002/jmri.1880040508

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Superparamagnetic iron oxide: pharmacokinetics and toxicity
Weissleder, R., Stark, D., Engelstad, B. L., Bacon, B., Compton, C. C., White, D., Jacobs, P. M., & Lewis, J. M. (1989) · American Journal of Roentgenology · doi:10.2214/ajr.152.1.167 · Cited by 1,045
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
Weissleder, R., Elizondo, G., WITTENBERG, J., Rabito, C. A., Bengele, H. H., & Josephson, L. (1990) · Radiology · doi:10.1148/radiology.175.2.2326474 · Cited by 1,027
Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.
Stark, D. D., Weissleder, R., Elizondo, G., Hahn, P. F., Saini, S., Todd, L. E., WITTENBERG, J., & Ferrucci, J. T. (1988) · Radiology · doi:10.1148/radiology.168.2.3393649 · Cited by 512
Book of Abstracts, Society of Magnetic Resonance in Medicine
Tanttu, J. I., & SEPPONEN, R. E. (1993) · Cited by 394
Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging.
Heiken, J. P., Weyman, P. J., Lee, J. K., Balfe, D. M., Picus, D. D., Brunt, E. M., & Flye, M. W. (1989) · Radiology · doi:10.1148/radiology.171.1.2538862 · Cited by 312
Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years
Ferrucci, J. T., & Stark, D. D. (1990) · American Journal of Roentgenology · doi:10.2214/ajr.155.5.2120963 · Cited by 279
Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation.
Nelson, R. C., CHEZMAR, J. L., Sugarbaker, P. H., & Bernardino, M. E. (1989) · Radiology · doi:10.1148/radiology.172.1.2662254 · Cited by 248
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
Hamm, B., Vogl, T. J., Branding, G., Schnell, B., Taupitz, M., Wolf, K. J., & Lissner, J. (1992) · Radiology · doi:10.1148/radiology.182.1.1309218 · Cited by 173
Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T.
Semelka, R. C., Shoenut, J. P., Kroeker, M. A., Greenberg, H. M., Simm, F. C., Minuk, G. Y., Kroeker, R. M., & Micflikier, A. B. (1992) · Radiology · doi:10.1148/radiology.184.3.1324509 · Cited by 166
Hepatic metastases: randomized, controlled comparison of detection with MR imaging and CT.
Stark, D. D., WITTENBERG, J., Butch, R. J., & Ferrucci, J. T. (1987) · Radiology · doi:10.1148/radiology.165.2.3310094 · Cited by 150

Flagged first, then by citations

Show all 25 references

Research works printed but not linked: 2

Harker LA, 1991, Future directions, Semin Hematol, 28, 73
World Health Organization, 1989, Radiocontrast media: labelling changes, FDA Drug Bull, 19, 138

Sorted by citations

Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,759
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181
Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy
Krishnan, K. M. (2010) · IEEE Transactions on Magnetics · doi:10.1109/tmag.2010.2046907 · Cited by 850
Application of Nanotechnology in Cancer Therapy and Imaging
Wang, X., Yang, L., Chen, Z., & Shin, D. M. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0003 · Cited by 704
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
Reimer, P., & Balzer, T. (2003) · European Radiology · doi:10.1007/s00330-002-1721-7 · Cited by 614
Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation
Kunzmann, A., Andersson, B., Buerki‐Thurnherr, T., Krug, H. F., Scheynius, A., & Fadeel, B. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.04.007 · Cited by 539
Cell toxicity of superparamagnetic iron oxide nanoparticles
Mahmoudi, M., Simchi, A., Milani, A. S., & Stroeve, P. (2009) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2009.04.046 · Cited by 376
Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia
Itô, A., Kuga, Y., Honda, H., Kikkawa, H., Horiuchi, A., Watanabe, Y., & Kobayashi, T. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.03.038 · Cited by 290
A multicenter validation of an active contour-based left ventricular analysis technique
Graves, M. J., Berry, E., Eng, A. A. B., Westhead, M., Black, R. T., Beacock, D. J., Kelly, S., & Niemi, P. (2000) · Journal of Magnetic Resonance Imaging · doi:10.1002/1522-2586(200008)12:2 · Cited by 21
One-Pot Synthesis of PEGylated Ultrasmall Iron-Oxide Nanoparticles and Their in Vivo Evaluation as Magnetic Resonance Imaging Contrast Agents
Lutz, J., Stiller, S., Hoth, A., Kaufner, L., Pison, U., & Cartier, R. (2006) · Biomacromolecules · doi:10.1021/bm0607527 · Cited by 251
Functionalized polystyrene nanoparticles as a platform for studying bio–nano interactions
Loos, C., Syrovets, T., Musyanovych, A., Mailänder, V., Landfester, K., Nienhaus, G. U., & Simmet, T. (2014) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.5.250 · Cited by 254
Gadolinium-Based Hybrid Nanoparticles as a Positive MR Contrast Agent
Hifumi, H., Yamaoka, S., Tanimoto, A., Citterio, D., & Suzuki, K. A. O. (2006) · Journal of the American Chemical Society · doi:10.1021/ja066442d · Cited by 239
Nanomedicine in Action: An Overview of Cancer Nanomedicine on the Market and in Clinical Trials
Wang, R., Billone, P. S., & Mullett, W. M. (2013) · Journal of Nanomaterials · doi:10.1155/2013/629681 · Cited by 237
Nanotechnology for Cancer Therapy
Narayan, M., & Pathak, V. (2006) · CRC Press eBooks · doi:10.1201/9781420006636 · Cited by 236
Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer
Gallo, J., Long, N. J., & Aboagye, E. O. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60149h · Cited by 232
Hepatic Lesion Detection: Comparison of MR Imaging after the Administration of Superparamagnetic Iron Oxide with Dual-Phase CT by Using Alternative-Free Response Receiver Operating Characteristic Analysis
Ward, J., Naik, K. S., Guthrie, J. A., Wilson, D. J., & Robinson, P. J. (1999) · Radiology · doi:10.1148/radiology.210.2.r99fe05459 · Cited by 228
Polyvinyl alcohol functionalized cobalt ferrite nanoparticles for biomedical applications
Salunkhe, A. B., Khot, V. M., Thorat, N. D., Phadatare, M., Sathish, C., Dhawale, D. S., & Pawar, S. H. (2012) · Applied Surface Science · doi:10.1016/j.apsusc.2012.10.073 · Cited by 219
Magnetic iron oxide nanoparticles as T 1 contrast agents for magnetic resonance imaging
Bao, Y., Sherwood, J. A., & Sun, Z. (2018) · Journal of Materials Chemistry C · doi:10.1039/c7tc05854c · Cited by 224
Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells
Kunzmann, A., Andersson, B., Vogt, C., Feliu, N., Ye, F., Gabrielsson, S., Toprak, M. S., Buerki‐Thurnherr, T., Laurent, S., Vahter, M., et al. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.03.011 · Cited by 199
Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes
Lunov, O., Syrovets, T., Röcker, C., Tron, K., Nienhaus, G. U., Rasche, V., Mailänder, V., Landfester, K., & Simmet, T. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.003 · Cited by 194
Hepatic MRI with SPIO: detection and characterization of focal liver lesions
Reimer, P., & Tombach, B. (1998) · European Radiology · doi:10.1007/s003300050535 · Cited by 188
Hepatic Lesion Detection and Characterization: Value of Nonenhanced MR Imaging, Superparamagnetic Iron Oxide-enhanced MR Imaging, and Spiral CT—ROC Analysis
Reimer, P., Jähnke, N., Fiebich, M., Schima, W., Deckers, F., Marx, C., Holzknecht, N., & Saini, S. (2000) · Radiology · doi:10.1148/radiology.217.1.r00oc31152 · Cited by 188
MR Contrast Agents for Liver Imaging: What, When, How
Gandhi, S. N., Brown, M. A., Wong, J. G., Aguirre, D. A., & Sirlin, C. B. (2006) · Radiographics · doi:10.1148/rg.266065014 · Cited by 164
Magnetic nanoparticles: material engineering and emerging applications in lithography and biomedicine
Bao, Y., Wen, T., Samia, A. C. S., Khandhar, A. P., & Krishnan, K. M. (2015) · Journal of Materials Science · doi:10.1007/s10853-015-9324-2 · Cited by 159
Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages
Lunov, O., Zablotskii, V., Syrovets, T., Röcker, C., Tron, K., Nienhaus, G. U., & Simmet, T. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.111 · Cited by 159
Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging
Taupitz, M., Wagner, S., Schnorr, J., Kravec, I., Pilgrimm, H., Bergmann-Fritsch, H., & Hamm, B. (2004) · Investigative Radiology · doi:10.1097/01.rli.0000129472.45832.b0 · Cited by 157
The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages
Lunov, O., Syrovets, T., Büchele, B., Jiang, X., Röcker, C., Tron, K., Nienhaus, G. U., Walther, P., Mailänder, V., Landfester, K., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.023 · Cited by 157
Caught in the Act:In VivoMapping of Macrophage Infiltration in Nerve Injury by Magnetic Resonance Imaging
Bendszus, M., & Stoll, G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10892.2003 · Cited by 152
The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles
Singh, N., Jenkins, G. J. S., Nelson, B. C., Marquis, B. J., Maffeïs, T. G. G., Brown, A., Williams, P. M., Wright, C. J., & Doak, S. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.087 · Cited by 150
Magnetic Iron Oxide Particles Coated with Carboxydextran for Parenteral Administration and Liver Contrasting
Lawaczeck, R., Bauer, H., Frenzel, T., Hasegawa, M., Ito, Y., Kito, K., Miwa, N., TSUTSUI, H., Vogler, H., & Weinmann, H. J. (1997) · Acta Radiologica · doi:10.1080/02841859709174391 · Cited by 148
Delivery of diagnostic agents for magnetic resonance imaging
Okuhata, Y. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00103-3 · Cited by 145
Superparamagnetic Iron Oxide Nanoparticles in Biomedicine: Applications and Developments in Diagnostics and Therapy
Ittrich, H., Peldschus, K., Raabe, N., Kaul, M. G., & Adam, G. (2013) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/s-0033-1335438 · Cited by 149
EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy
Yang, H., Lin, Y.-J., Lin, K., Hsu, S., Huang, C.-Y., She, S.-H., Liu, H.-L., Lin, C.-W., Xiao, M.-C., Wey, S., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.007 · Cited by 141
MR imaging contrast agents — what's in a name?
Mitchell, D. G. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070102 · Cited by 126
Contrast-enhanced Blood-Pool MR Angiography with Optimized Iron Oxides: Effect of Size and Dose on Vascular Contrast Enhancement in Rabbits
Allkemper, T., Bremer, C., Matuszewski, L., Ebert, W., & Reimer, P. (2002) · Radiology · doi:10.1148/radiol.2232010241 · Cited by 124
Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications
Frtús, A., Smolková, B., Uzhytchak, M., Lunová, M., Jirsa, M., Kubinová, Š., Dejneka, A., & Lunov, O. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.036 · Cited by 119
R2 and R2* Mapping for Sensing Cell-bound Superparamagnetic Nanoparticles: In Vitro and Murine in Vivo Testing
Kuhlpeter, R., Dahnke, H., Matuszewski, L., ten Persigehl, T., von Wallbrunn, A., Allkemper, T., Heindel, W. L., Schaeffter, T., & Bremer, C. (2007) · Radiology · doi:10.1148/radiol.2451061345 · Cited by 110
Targeted delivery of doxorubicin into tumor cells via MMP-sensitive PEG hydrogel-coated magnetic iron oxide nanoparticles (MIONPs)
Nazli, C., Demirer, G. S., Yar, Y., Acar, H. Y., & Kızılel, S. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.07.049 · Cited by 101
The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core–shell nanoparticles
Lee, P.-W., Hsu, S., Wang, J., Tsai, J.-S., Lin, K., Wey, S., Chen, F., Lai, C., Yen, T., & Sung, H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.010 · Cited by 102
Magnetic Resonance Imaging of Focal Liver Lesions
Vogl, T. J., Hammerstingl, R., Schwarz, W., Kümmel, S., Müller, P., Balzer, T., Lauten, M., Balzer, J. O., Mack, M. G., Schimpfky, C., et al. (1996) · Investigative Radiology · doi:10.1097/00004424-199611000-00004 · Cited by 98
Non‐Invasive Synergistic Treatment of Brain Tumors by Targeted Chemotherapeutic Delivery and Amplified Focused Ultrasound‐Hyperthermia Using Magnetic Nanographene Oxide
Yang, H., Hua, M., Hwang, T., Lin, K., Huang, C., Tsai, R., Ma, C.-C. M., Hsu, P., Wey, S., Hsu, P., et al. (2013) · Advanced Materials · doi:10.1002/adma.201301046 · Cited by 92
Individually Stabilized, Superparamagnetic Nanoparticles with Controlled Shell and Size Leading to Exceptional Stealth Properties and High Relaxivities
Lassenberger, A., Scheberl, A., Stadlbauer, A., Stiglbauer, A., Helbich, T. H., & Reimhult, E. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12932 · Cited by 87
Organ-specific toxicity of magnetic iron oxide-based nanoparticles
Chrishtop, V. V., Mironov, V. A., Prilepskii, A. Y., Nikonorova, V. G., & Vinogradov, V. V. (2021) · Nanotoxicology · doi:10.1080/17435390.2020.1842934 · Cited by 86
Gold-Based Magneto/Optical Nanostructures: Challenges for In Vivo Applications in Cancer Diagnostics and Therapy
Melancon, M. P., Lü, W., & Li, C. (2009) · MRS Bulletin · doi:10.1557/mrs2009.117 · Cited by 86
Toxicity of Metal and Metal Oxide Nanoparticles
Karlsson, H. L., Toprak, M. S., & Fadeel, B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-59453-2.00004-4 · Cited by 87
A single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB/c mice
Jan, T., Shen, Wang, C., & Liao (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s21019 · Cited by 79
Determination of Plasma Protein Adsorption on Magnetic Iron Oxides: Sample Preparation
Thode, K., Lück, M., Semmler, W., Müller, R. H., & Kresse, M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012104017761 · Cited by 74
Remote Actuation of Apoptosis in Liver Cancer Cells via Magneto-Mechanical Modulation of Iron Oxide Nanoparticles
Lunov, O., Uzhytchak, M., Smolková, B., Lunová, M., Jirsa, M., Dempsey, N. M., Dias, A., Bonfim, M. J. C., Hof, M., Jurkiewicz, P., et al. (2019) · Cancers · doi:10.3390/cancers11121873 · Cited by 75
Long circulating tracer tailored for magnetic particle imaging
Liu, S., Chiu‐Lam, A., Rivera‐Rodriguez, A., DeGroff, R., Savliwala, S., Sarna, N. S., & Rinaldi, C. (2021) · Nanotheranostics · doi:10.7150/ntno.58548 · Cited by 73
Nephrotoxic Nephritis and Obstructive Nephropathy: Evaluation with MR Imaging Enhanced with Ultrasmall Superparamagnetic Iron Oxide—Preliminary Findings in a Rat Model
Hauger, O., Delalande, C., Deminière, C., Fouqueray, B. L., Ohayon, C., Garcia, S., Trillaud, H., Combe, C., & Grenier, N. (2000) · Radiology · doi:10.1148/radiology.217.3.r00dc04819 · Cited by 72
Iron oxide nanoparticles suppressed T helper 1 cell-mediated immunity in a murine model of delayed-type hypersensitivity
Jan, T., Shen, Liang, Wang, C., & Liao (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31054 · Cited by 68
Hepatic Lesion Detection after Superparamagnetic Iron Oxide Enhancement: Comparison of Five T2-weighted Sequences at 1.0 T by Using Alternative-Free Response Receiver Operating Characteristic Analysis
Ward, J., Chen, F., Guthrie, J. A., Wilson, D. J., Lodge, J. P. A., Wyatt, J. I., & Robinson, P. J. (2000) · Radiology · doi:10.1148/radiology.214.1.r00ja21159 · Cited by 68
Detection of Malignant Hepatic Tumors
Matsuo, M., Kanematsu, M., Itoh, K., Ito, K., Maetani, Y. S., Kondo, H., Kako, N., Matsunaga, N., Hoshi, H., & Shiraishi, J. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.177.3.1770637 · Cited by 66
Hepatocellular Carcinoma in Cirrhosis: Enhancement Patterns at Dynamic Gadolinium- and Superparamagnetic Iron Oxide–enhanced T1-weighted MR Imaging
Lutz, A. M., Willmann, J. K., Goepfert, K., Marinček, B., & Weishaupt, D. (2005) · Radiology · doi:10.1148/radiol.2372041183 · Cited by 63
First‐pass and equilibrium‐MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study
Tombach, B., Reimer, P., Bremer, C., Allkemper, T., Engelhardt, M., Mahler, M., Ebert, W., & Heindel, W. L. (2004) · NMR in Biomedicine · doi:10.1002/nbm.906 · Cited by 63
Intrahepatic splenosis: imaging features
Vuysere, S. D., Steenbergen, W. V., Aerts, R., Hauwaert, H. V., Beckevoort, D. V., & Hoe, L. V. (2000) · Abdominal Imaging · doi:10.1007/s002619910042 · Cited by 61
Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis
Ma, Y., Yang, H., Hua, Lin, K., Wey, Wu, S., Lu, Y.-C., Liu, & Wu, T. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32939 · Cited by 58
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
Uzhytchak, M., Smolková, B., Lunová, M., Frtús, A., Jirsa, M., Dejneka, A., & Lunov, O. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114828 · Cited by 61
Ultrathin Iron Oxide Nanowhiskers as Positive Contrast Agents for Magnetic Resonance Imaging
Macher, T., Totenhagen, J. W., Sherwood, J. A., Qin, Y., Gurler, D., Bolding, M., & Bao, Y. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201403436 · Cited by 58
Superparamagnetic iron oxide (SPIO)‐enhanced liver MRI with ferucarbotran: Efficacy for characterization of focal liver lesions
Namkung, S., Zech, C. J., Helmberger, T. K., Reiser, M. F., & Schoenberg, S. O. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20873 · Cited by 54
Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A)
Kehagias, D. T., Gouliamos, A. D., Smyrniotis, V. E., & Vlahos, L. J. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1224 · Cited by 54
Iron Oxide Nanoparticles: Physicochemical Characteristics and Historical Developments to Commercialization for Potential Technological Applications
Etemadi, H., Buchanan, J. K., Kandile, N. G., & Plieger, P. G. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00938 · Cited by 53
Radiofrequency Ablation of the Liver: Determination of Ablative Margin at MR Imaging with Impaired Clearance of Ferucarbotran—Feasibility Study
Mori, K., Fukuda, K., Asaoka, H., Ueda, T., Kunimatsu, A., Okamoto, Y., Nasu, K., Fukunaga, K., Morishita, Y., & Minami, M. (2009) · Radiology · doi:10.1148/radiol.2512081161 · Cited by 51
Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64).
Kobayashi, H., Saga, T., Kawamoto, S., Sato, N., Hiraga, A., Ishimori, T., Konishi, J., Togashi, K., & Brechbiel, M. W. (2001) · PubMed · Cited by 51
Hyperthermia generated with ferucarbotran (Resovist®) in an alternating magnetic field enhances cisplatin-induced apoptosis of cultured human oral cancer cells
Sato, I., Umemura, M., Mitsudo, K., Kioi, M., Nakashima, H., Iwai, T., Feng, X., Oda, K., Miyajima, A., Makino, A., et al. (2014) · The Journal of Physiological Sciences · doi:10.1007/s12576-014-0309-8 · Cited by 50
Contrast agents for MR imaging of the liver
Low, R. N. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070109 · Cited by 48
Iron‐induced myocardial injury: an alarming side effect of superparamagnetic iron oxide nanoparticles
Shen, Y., Huang, Z., Liu, X., Qian, J., Xu, J., Yang, X., Sun, A., & Ge, J. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12582 · Cited by 46
Magnetic core–shell nanowires as MRI contrast agents for cell tracking
Martínez-Banderas, A. I., Aires, A., Plaza‐García, S., Colás, L., Moreno, J. A., Ravasi, T., Merzaban, J. S., Ramos‐Cabrer, P., Cortajarena, A. L., & Kosel, J. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00597-3 · Cited by 46
Magnetic particle imaging for assessment of cerebral perfusion and ischemia
Ludewig, P., Graeser, M., Forkert, N. D., Thieben, F., Rández‐Garbayo, J., Rieckhoff, J., Lessmann, K., Foerger, F., Szwargulski, P., Magnus, T. U., et al. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1757 · Cited by 45
MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents
Chen, F., Ward, J., & Robinson, P. J. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(98)00193-3 · Cited by 44
Iron Oxide Nanoparticles as Promising Antibacterial Agents of New Generation
Zhang, T.-G., & Miao, C. (2024) · Nanomaterials · doi:10.3390/nano14151311 · Cited by 49
Iron Oxide Nanoparticle-Induced Autophagic Flux Is Regulated by Interplay between p53-mTOR Axis and Bcl-2 Signaling in Hepatic Cells
Uzhytchak, M., Smolková, B., Lunová, M., Jirsa, M., Frtús, A., Kubinová, Š., Dejneka, A., & Lunov, O. (2020) · Cells · doi:10.3390/cells9041015 · Cited by 44
SPIO‐enhanced 2D‐TOF MR angiography of the portal venous system: Results of an intraindividual comparison
Reimer, P., Marx, C., Rummeny, E. J., Müller, M., Lentschig, M. G., Balzer, T., Dietl, K., Sulkowski, U., Berns, T., Shamsi, K., et al. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070602 · Cited by 44
Iron Oxide Nanoparticles: The precise strategy for targeted delivery of genes, oligonucleotides and peptides in cancer therapy
Sachdeva, V., Monga, A., Vashisht, R., Singh, D., Singh, A., & Bedi, N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103585 · Cited by 45
Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability
Metz, S., Beer, A. J., Settles, M., Pelisek, J., Botnar, R. M., Rummeny, E. J., & Heider, P. (2010) · International journal of cardiac imaging · doi:10.1007/s10554-010-9736-7 · Cited by 43
LIVER II: IRON OXIDE-BASED RETICULOENDOTHELIAL CONTRAST AGENTS FOR MR IMAGING
Petersein, J., Saini, S., & Weissleder, R. (1996) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/s1064-9689(21)00553-5 · Cited by 43
Coronary arteries
Wielopolski, P. A., van Geuns, R., de Feyter, P. J., & Oudkerk, M. (2000) · European Radiology · doi:10.1007/s003300050004 · Cited by 43
Superparamagnetic Iron Oxide (SPIO) MRI Contrast Agent for Bone Marrow Imaging: Differentiating Bone Metastasis and Osteomyelitis
Fukuda, Y., Ando, K., Ishikura, R., Kotoura, N., Tsuda, N., Kato, N., Yoshiya, S., & Nakao, N. (2006) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.5.191 · Cited by 42
Shape-dependent cellular behaviors and relaxivity of iron oxide-based T 1 MRI contrast agents
Sherwood, J. A., Lovas, K., Rich, M. C., Yin, Q., Lackey, K., Bolding, M., & Bao, Y. (2016) · Nanoscale · doi:10.1039/c6nr06158c · Cited by 41
A role of cellular glutathione in the differential effects of iron oxide nanoparticles on antigen-specific T cell cytokine expression
Jan, T., Shen, Liang, Wang, C., & Liao (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25588 · Cited by 41
Fast magnetic resonance imaging of liver
Ichikawa, T., & Araki, T. (1999) · European Journal of Radiology · doi:10.1016/s0720-048x(98)00176-4 · Cited by 41
Magnetic particle imaging: kinetics of the intravascular signal in vivo
Haegele, J., Lüdtke-Buzug, K., Schaecke, C., Graeser, M., Duschka, R. L., Panagiotopoulos, N., Buzug, T. M., VOGT, F. M., & Barkhausen, J. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s49976 · Cited by 40
Application of a superparamagnetic iron oxide (Resovis®) for MR imaging of human cerebral blood volume
Reimer, P., Schuierer, G. R., Balzer, T., & Peters, P. E. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910340507 · Cited by 39
Contrast enhancement with GD‐EOB‐DTPA in MR imaging of hepatocellular carcinoma in mice: A comparison with superparamagnetic iron oxide
Fujita, M., Yamamoto, R., Fritz‐Zieroth, B., Yamanaka, T., Takahashi, M., Miyazawa, T., Tatsuta, M., Terada, N., Hosomi, N., Inoue, E., et al. (1996) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880060310 · Cited by 39
Linker-free conjugation and specific cell targeting of antibody functionalized iron-oxide nanoparticles
Xu, Y., Baiu, D. C., Sherwood, J. A., McElreath, M. R., Qin, Y., Lackey, K., Otto, M., & Bao, Y. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00840e · Cited by 38
Key factors in the acquisition of contrast kinetic data for oncology
Evelhoch, J. L. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3 · Cited by 366
Magnetic resonance hypointensive signal primarily originates from extracellular iron particles in the long-term tracking of mesenchymal stem cells transplanted in the infarcted myocardium
Ge, J., Huang, Z., Li, C., Yang, S., Xu, J., Shen, Y., Xie, X., Dai, Y., Lu, H., Gong, H., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77858 · Cited by 32
Focal Liver Lesions: SPIO-, Gadolinium-, and Ferucarbotran-enhanced Dynamic T1-weighted and Delayed T2-weighted MR Imaging in Rabbits
Schnorr, J., Wagner, S., Abramjuk, C., Drees, R., Schink, T., Schellenberger, E. A., Pilgrimm, H., Hamm, B., & Taupitz, M. (2006) · Radiology · doi:10.1148/radiol.2393040884 · Cited by 32
NEW MR IMAGING CONTRAST AGENTS
Earls, J. P., & Bluemke, D. A. (1999) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/s1064-9689(21)00021-0 · Cited by 30
In vivo magnetic particle imaging: angiography of inferior vena cava and aorta in rats using newly developed multicore particles
Mohtashamdolatshahi, A., Kratz, H., Kosch, O., Hauptmann, R., Stolzenburg, N., Wiekhorst, F., Sack, I., Hamm, B., Taupitz, M., & Schnorr, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-74151-4 · Cited by 29
Focal Liver Lesions: Detection and Characterization at Double-Contrast Liver MR Imaging with Ferucarbotran and Gadobutrol versus Single-Contrast Liver MR Imaging
Heilmaier, C., Lutz, A. M., Bolog, N. V., Weishaupt, D., Seifert, B., & Willmann, J. K. (2009) · Radiology · doi:10.1148/radiol.2533090161 · Cited by 29
Prolonging the circulatory retention of SPIONs using dextran sulfate: in vivo tracking achieved by functionalisation with near-infrared dyes
Abdollah, M. R. A., Kalber, T. L., Tolner, B., Southern, P., Bear, J. C., Robson, M. P., Pedley, R. B., Parkin, I. P., Pankhurst, Q. A., Mulholland, P. J., et al. (2014) · Faraday Discussions · doi:10.1039/c4fd00114a · Cited by 28
Iron particles enhance visualization of experimental gliomas with high-resolution sonography.
Nolte, I. S., Vince, G. H., Mäurer, M., Herbold, C., Goldbrunner, R., Solymosi, L., Stoll, G., & Bendszus, M. (2005) · PubMed Central · Cited by 27
Effect of hydrophilicity and agmatine modification on degradation of poly(propylene fumarate‐co‐ethylene glycol) hydrogels
Tanahashi, K., & Mikos, A. G. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10147 · Cited by 26
Preliminary experience with superparamagnetic iron oxide-enhanced dynamic magnetic resonance imaging and comparison with contrast-enhanced computed tomography in endoleak detection after endovascular aneurysm repair
Ichihashi, S., Marugami, N., Tanaka, T., Iwakoshi, S., Kurumatani, N., Kitano, S., Nogi, A., & Kichikawa, K. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2012.12.061 · Cited by 25
Contrast agents for MR imaging of the liver: a clinical overview
Mahfouz, A. E., Hamm, B., & Taupitz, M. (1997) · European Radiology · doi:10.1007/s003300050193 · Cited by 25
Contrast Media for X-ray and Magnetic Resonance Imaging
Frenzel, T., Lawaczeck, R., Taupitz, M., Jošt, G., Lohrke, J., Sieber, M. A., & Pietsch, H. (2015) · Investigative Radiology · doi:10.1097/rli.0000000000000193 · Cited by 24
In vitro labelling of mouse embryonic stem cells with SPIO nanoparticles.
Krejčí, J., Pachernı́k, J., Hampl, A., & Dvořák, P. (2008) · PubMed · Cited by 24
Immunological impact of magnetic nanoparticles (Ferucarbotran) on murine peritoneal macrophages
Yeh, C., Hsiao, J., Wang, J., & Sheu, F. (2009) · Journal of Nanoparticle Research · doi:10.1007/s11051-009-9589-y · Cited by 24
Magnetic resonance imaging in the detection of focal liver lesions: comparison of dynamic contrast-enhanced TurboFLASH and T 2 weighted spin echo images
Ward, J., Baudouin, C. J., Ridgway, J. P., & RObinson, P. J. (1995) · British Journal of Radiology · doi:10.1259/0007-1285-68-809-463 · Cited by 24

Authors: Hamm, B., Staks, T., Taupitz, M., Maibauer, R., Speidel, A., Huppertz, A., Frenzel, T., Lawaczeck, R., Wolf, K. J., & Lange, L.
Affiliations: Humboldt-Universität zu Berlin (DE)
Freie Universität Berlin (DE)
Corresponding author: Hamm, Bernd
ORCID: Hamm, Bernd
Taupitz, Matthias
Huppertz, Alexander
Lawaczeck, Rüdiger
Venue: Journal of Magnetic Resonance Imaging
Publisher: Wiley
Published: 1994-09
Volume: 4
Issue: 5
Pages: 659-668
ISSN: 1053-1807 (ISSN-L)
1522-2586
DOI: 10.1002/jmri.1880040508
OpenAlex: W2163391474
Cited by: 187
References: 25
Citations by year: 2024: 5 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 7 · 2019: 6 · 2018: 4 · 2017: 3 · 2016: 4 · 2015: 5 · 2014: 10 · 2013: 15 · 2012: 5
FWCI: 8.80
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 4100 d)
Locations: Journal of Magnetic Resonance Imaging (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
Physical Sciences › Materials Science › Materials Chemistry › Lanthanide and Transition Metal Complexes
Keywords: superparamagnetic iron oxide nanoparticles, MRI contrast agents, liver imaging, spleen imaging, contrast-enhanced MRI, safety and tolerability, activated partial thromboplastin time
MeSH terms: Adult, Contrast Media, Dextrans, Dose-Response Relationship, Drug, Drug Tolerance, Humans, Image Enhancement, Injections, Intravenous, Iron, Liver, Magnetic Resonance Imaging, Male, Oxides, Partial Thromboplastin Time, Placebos, Prospective Studies, Spleen, Suspensions, Single-Blind Method, Ferrosoferric Oxide, Magnetite Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks